Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains - Journal of Thoracic Oncology

Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains - Journal of Thoracic Oncology

Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains

Chenguang Li, MD*,†,1

, 

Yihua Sun, MD*,†,1

, 

Rong Fang, BS‡

, 

Xiangkun Han, BS‡

, 

Xiaoyang Luo, MD*,†

, 

Rui Wang, MD*,†

, 

Yunjian Pan, MD*,†

, 

Haichuan Hu, MD*,†

, 

Yang Zhang, MD*,†

, 

William Pao, MD§

, 

Lei Shen, MD∥,***,Correspondence information about the author MD Lei ShenEmail the author MD Lei Shen

, 

Hongbin Ji, PhD‡,**,Correspondence information about the author PhD Hongbin JiEmail the author PhD Hongbin Ji

, 

Haiquan Chen, MD*,†,*,Correspondence information about the author MD Haiquan ChenEmail the author MD Haiquan Chen

Open Archive

PlumX Metrics

DOI: https://doi.org/10.1097/JTO.0b013e318234f0a2